SCHEMBL13154603

SCHEMBL13154603

O=C(O)COc1ccc(/N=N/c2c(O)ccc3cc(Br)ccc23)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTRC Q99895 1/20 0.74
▸ THRB P10828 5/20 0.46
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ MAPT P10636 7/20 0.41
▸ MEN1 O00255 7/20 0.41
▸ KMT2A Q03164 7/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ PKM P14618 1/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ RECQL P46063 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALPL P05186 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ ALPG P10696 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ MMP14 P50281 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13154605 0.87 CTRC (0.56) CTRCTHRBCYP1A2CYP2C9MAPT
SCHEMBL7812766 0.85 CTRC (1.00) CTRCMAPTMEN1KMT2AALDH1A1
SCHEMBL7825919 0.83 THRB (0.63) CTRCTHRBMAPTMEN1KMT2A
SCHEMBL7825916 0.83 THRB (0.63) CTRCTHRBMAPTMEN1KMT2A
SCHEMBL13154600 0.75 CTRC (0.55) CTRCMAPTMEN1KMT2AALDH1A1
SCHEMBL7422807 0.74 PTPN7 (0.69) CTRCMEN1KMT2AL3MBTL1TDP1
SCHEMBL18286211 0.72 PTPN7 (0.70) CTRCMEN1KMT2AL3MBTL1TDP1
SCHEMBL31742271 0.71 ALOX15 (0.55) CTRCTHRBMAPTMEN1KMT2A
SCHEMBL25281838 0.71 PTGDR2 (0.57) CTRCKMT2APKML3MBTL1TDP1
SCHEMBL7713953 0.70 ALOX15 (0.68) CTRCMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7803966-B2 Cosmetic and pharmaceutical compositions comprising compounds that display retinoid like activities JOHNSON & JOHNSON CONSUMER FRANCE, S.A.S. (FR) 2010-09-28 — — US disclosed
US-7803966-B2 Cosmetic and pharmaceutical compositions comprising compounds that display retinoid like activities JOHNSON & JOHNSON CONSUMER FRANCE, S.A.S. (FR) 2010-09-28 — — US disclosed
US-20090203654-A1 COSMETIC AND PHARMACEUTICAL COMPOSITIONS KENVUE HOLDINGS FRANCE (FR) 2009-08-13 — — US disclosed
US-20090203654-A1 COSMETIC AND PHARMACEUTICAL COMPOSITIONS KENVUE HOLDINGS FRANCE (FR) 2009-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203654-A1 COSMETIC AND PHARMACEUTICAL COMPOSITIONS EGFR, HDGF, CXCL8 CTRC 3410/4885THRB 609/4885CYP1A2 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback